MyMyelomaTeam

Yes, a multiple myeloma patient's risk status can change over time, particularly after relapse. Most people respond well to their first-line therapy for about 2-3 years before experiencing a relapse. When relapse occurs, doctors need to completely reevaluate the treatment plan since the disease characteristics may have Show Full Answer

Yes, a multiple myeloma patient's risk status can change over time, particularly after relapse. Most people respond well to their first-line therapy for about 2-3 years before experiencing a relapse. When relapse occurs, doctors need to completely reevaluate the treatment plan since the disease characteristics may have changed. The timing of relapse can indicate risk level - very early relapses, especially within the first year after treatment, may suggest high-risk disease. If minimal residual disease (MRD) is detected after treatment is complete, it often indicates a higher likelihood of earlier relapse. Your hematologist-oncologist will use various testing methods including blood work, imaging, and bone marrow analysis to assess disease status and risk level after relapse.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Myeloma Relapse Rates and 9 Treatment Options for Relapses